Korina Tanner, MD
Family Practice · El Dorado Hills
- Medicare standing
- Clear
- Enrolled, allowed to bill and order, not excluded
- Plans that list them
- Not verified
- Not the same as out of network.
- Offices
- 4
Offices
4 locations · Sutter Valley Medical Foundation · Sutter Bay Medical Foundation
Looking this up.
Hospitals listed: Sutter Roseville Medical Center. That is not proof they admit you there this week.
Plan participation
Not verified
We could not verify current plan participation for this doctor. This does not mean they are out of network. Call Dr. Tanner’s office to ask if they take your plan before you enroll.
California Medical Board record
Licence C133122 · Current
Licensed to practise in California · since 2014 · expires 2028-06-30 · Creighton University School of Medicine.
No disciplinary actions, convictions, malpractice judgments or citations in this record.
State licence records
1 licence
- Washington MD.MD.00037673Physician And Surgeon License · since 1999 · expires 2019-06-18ExpiredNo board action on this licenceCheck it with the state
We check Colorado, Delaware, Florida, Illinois, Maryland, New Jersey, New York, Tennessee, Texas, Virginia, Washington, plus California above. A state that is not in this list has not been checked, which is not the same as clear.
Hospitals they work in
1 hospital
These rate the hospital, not this clinician. Most measures at most hospitals are no different from the national rate.
- Sutter Roseville Medical CenterRoseville, CAAcute Care Hospital · Voluntary non-profit - Private · Has an emergency department · Birthing-friendlyPart of Sutter Health, which runs 27 hospitals in 2 statesPatients rate it 4 of 5 · 79% would definitely recommend itOverall rating: 5 of 5 starsBetter than the national rate — Pressure ulcer rate: 0.08 (0 to 0.56) · 12,400 cases, Jul 2022 – Jun 2024Better than the national rate — Catheter Associated Urinary Tract Infections (ICU + select Wards): 0.069, Oct 2024 – Sep 2025Better than the national rate — Central Line Associated Bloodstream Infection (ICU + select Wards): 0.262, Oct 2024 – Sep 2025Better than the national rate — Clostridium Difficile (C.Diff): 0.128, Oct 2024 – Sep 2025Better than the national rate — MRSA Bacteremia: 0.357, Oct 2024 – Sep 2025
See every measure and the patient survey for Sutter Roseville Medical Center
Behind the star rating — Deaths: 2 better, 5 the same, 0 worse of 7 measures. Safety: 5 better, 1 the same, 1 worse of 7 measures. Readmissions: 2 better, 7 the same, 1 worse of 10 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Pressure ulcer rateComplications and deaths | 0.08 (0 to 0.56) · 12,400 cases | Better | Jul 2022 – Jun 2024 |
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 0.069 | Better | Oct 2024 – Sep 2025 |
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 0.262 | Better | Oct 2024 – Sep 2025 |
| Clostridium Difficile (C.Diff)Infections | 0.128 | Better | Oct 2024 – Sep 2025 |
| MRSA BacteremiaInfections | 0.357 | Better | Oct 2024 – Sep 2025 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 1.33 (0.49 to 2.17) · 2,916 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 0.9 (0.63 to 1.17) | No different | Jul 2022 – Jun 2024 |
| Death rate among surgical inpatients with serious treatable complicationsComplications and deaths | 147.2 (107.33 to 187.07) · 191 cases | No different | Jul 2022 – Jun 2024 |
| Death rate for COPD patientsComplications and deaths | 7.9 · 250 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart attack patientsComplications and deaths | 10.7 · 484 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 9.4 · 839 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 13.3 · 1,027 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 10 · 656 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 2.8 · 6,822 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.25 (0.08 to 0.42) · 14,300 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.23 (0.06 to 0.41) · 14,490 cases | No different | Jul 2022 – Jun 2024 |
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 4.43 (2.77 to 6.08) · 3,117 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 1.38 (0 to 2.95) · 938 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 2.06 (0.76 to 3.36) · 2,944 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative respiratory failure rateComplications and deaths | 9.03 (2.8 to 15.25) · 840 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 6.43 (3.11 to 9.75) · 899 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 1.73 (0.34 to 3.11) · 819 cases | No different | Jul 2022 – Jun 2024 |
| Rate of complications for hip/knee replacement patientsComplications and deaths | 4.4 · 35 cases | None | Apr 2023 – Mar 2025 |
| SSI - Colon SurgeryInfections | 0.41 | No different | Oct 2024 – Sep 2025 |
| Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits | 13.9 · 527 cases | None | Jul 2023 – Jun 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 20.6 · 1,094 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart attack patientsUnplanned return visits | -16.6 · 443 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | -11 · 961 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | -8 · 1,064 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 17.1 · 1,293 cases | None | Jul 2023 – Jun 2025 |
| Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits | 5.5 (3.5 to 8.7) · 35 cases | No different | Jan 2024 – Dec 2024 |
| Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits | 10.2 (6.9 to 14.9) · 35 cases | No different | Jan 2024 – Dec 2024 |
| Rate of readmission after hip/knee replacementUnplanned return visits | 5.4 · 36 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 18.5 · 310 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 13.2 (9.8 to 17.9) · 116 cases | No different | Jan 2022 – Dec 2024 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 0.8 (0.7 to 1) · 1,600 cases | No different | Jan 2024 – Dec 2024 |
What patients said (537 patients answered, 24% of those asked)
| Cleanliness | 4 |
| Nurse communication | 4 |
| Doctor communication | 3 |
| Communication about medicines | 3 |
| Discharge information | 4 |
| Overall hospital rating | 4 |
| Quietness | 3 |
| Recommend hospital | 5 |
| Room was "always" clean | 74% |
| Nurses "always" communicated well | 80% |
| Doctors "always" communicated well | 77% |
| Staff "always" explained | 62% |
| Yes, staff "did" give patients this information | 89% |
| Yes, staff "did" give patients information about help after discharge | 88% |
| Doctors "always" explained things so they could understand | 70% |
| Doctors "always" listened carefully | 76% |
| Doctors "always" treated them with courtesy and respect | 84% |
| Patients who gave a rating of "9" or "10" (high) | 77% |
| Staff "always" explained new medications | 77% |
| Nurses "always" explained things so they could understand | 78% |
| Nurses "always" listened carefully | 75% |
| Nurses "always" treated them with courtesy and respect | 86% |
| "Always" quiet at night | 52% |
| "YES", patients would definitely recommend the hospital | 79% |
| Staff "always" explained possible side effects | 47% |
| Yes, staff "did" give patients information about possible symptoms | 90% |
Original Medicare doctor bills
$19,856
Medicare paid this office $19,856 for 180 people.
This is what Medicare paid the clinician — not Medicare Advantage, and not the pharmacy.
| Return visit (30+ min) | 175 | $16,786 | $89 |
| Automated urinalysis test | 30 | $68 | $2 |
Who their Medicare patients are
180 Original Medicare patients in 2024. Average age 75 · Women 61% · Health risk score 0.96. At or below the middle of the specialty; the typical family practice clinician is at 1.13.
Conditions among them: High blood pressure 64% · Coronary heart disease 23% · Chronic kidney disease 22% · Diabetes 18% · Cancer 17% · Atrial fibrillation 17% · Depression 17% · Heart failure 12% · COPD 12% · Dementia 7% · Stroke 7%.
The office billed $78,249, Medicare allowed $29,187 and paid $19,856; for 293 services of 31 kinds.
Original Medicare patients only. A risk score of 1.0 is the average Medicare patient; higher means sicker. Any count under 11 is hidden.
Year by year
| 2024 | 180 | 293 | 75 | 0.96 | $78,249 | $19,856 |
| 2023 | 243 | 441 | 75 | 1.08 | $102,785 | $27,840 |
| 2022 | 176 | 280 | 73 | 0.94 | $65,713 | $19,636 |
| 2021 | 86 | 153 | 72 | 1.08 | $32,848 | $9,981 |
| 2020 | 85 | 140 | 73 | 1.27 | $32,847 | $7,568 |
| 2019 | 124 | 225 | 73 | 1.18 | $33,414 | $7,088 |
| 2018 | 347 | 680 | 72 | 1.12 | $93,076 | $21,953 |
| 2017 | 279 | 647 | 72 | 1.09 | $91,941 | $23,057 |
| 2016 | 105 | 194 | 71 | 1.11 | $28,424 | $7,850 |
| 2015 | 32 | 73 | 71 | 1.18 | $8,869 | $2,188 |
| 2014 | 199 | 343 | 67 | 1.08 | $53,237 | $13,475 |
| 2013 | 116 | 214 | 68 | 0.97 | $28,458 | $8,052 |
Original Medicare only. A service billed for fewer than 11 people in a year is hidden, so the lines can add up to less than the year's total.
See the services billed each year
2023: 5 services
| Return visit (30+ min) | 235 | $23,697 | $91 |
| Detection test by multiplex amplified probe technique for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (covid-19), influenza virus types a and b, and respiratory syncytial virus | 11 | $1,538 | $140 |
| Detection test by immunoassay technique for streptococcus, group a (strep) | 16 | $264 | $16 |
| Detection test by immunoassay with direct visual observation for influenza virus | 13 | $260 | $16 |
| Automated urinalysis test | 34 | $77 | $2 |
2022: 4 services
| Return visit (30+ min) | 172 | $17,494 | $96 |
| Amplifed dna or rna probe detection of severe acute respiratory syndrome coronavirus 2 (covid-19) antigen | 28 | $1,415 | $51 |
| Detection test by immunoassay with direct visual observation for streptococcus, group a (strep) | 16 | $260 | $16 |
| Automated urinalysis test | 22 | $51 | $2 |
2021: 2 services
| Return visit (30+ min) | 82 | $8,683 | $98 |
| Automated urinalysis test | 13 | $32 | $2 |
2020: 1 service
| Return visit (30+ min) | 72 | $5,412 | $72 |
2019: 5 services
| Return visit (30+ min) | 75 | $5,407 | $69 |
| Short return visit (20+ min) | 11 | $453 | $41 |
| Detection test by immunoassay with direct visual observation for streptococcus, group a (strep) | 11 | $178 | $16 |
| Injection of drug or substance under skin or into muscle | 12 | $129 | $11 |
| Automated urinalysis test | 39 | $98 | $2 |
2018: 11 services
| Return visit (30+ min) | 208 | $16,665 | $71 |
| Short return visit (20+ min) | 18 | $915 | $48 |
| Detection test by immunoassay with direct visual observation for streptococcus, group a (strep) | 38 | $632 | $16 |
| Injection of drug or substance under skin or into muscle | 18 | $381 | $17 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | 24 | $290 | $12 |
| Automated urinalysis test | 103 | $287 | $3 |
| Office for the evaluation and management of established patient that may not require presence of healthcare professional | 12 | $198 | $17 |
| Detection test by immunoassay with direct visual observation for influenza virus | 12 | $195 | $16 |
| Inhalation treatment for airway obstruction or sputum production | 12 | $164 | $14 |
| Ipratropium bromide, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose form, per milligram | 12 | $2 | None |
| Albuterol, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose, 1 mg | 12 | $1 | None |
2017: 7 services
| Return visit (30+ min) | 162 | $13,809 | $77 |
| Short return visit (20+ min) | 64 | $4,084 | $52 |
| Injection of drug or substance under skin or into muscle | 21 | $521 | $20 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | 32 | $423 | $12 |
| Automated urinalysis test | 80 | $248 | $3 |
| Detection test by immunoassay with direct visual observation for streptococcus, group a (strep) | 15 | $187 | $12 |
| Injection, ceftriaxone sodium, per 250 mg | 13 | $26 | None |
2016: 2 services
| Return visit (30+ min) | 55 | $4,670 | $85 |
| Short return visit (20+ min) | 27 | $1,489 | $55 |
2015: 2 services
| Return visit (30+ min) | 17 | $1,286 | $76 |
| Short return visit (20+ min) | 14 | $643 | $46 |
2014: 5 services
| Return visit (30+ min) | 91 | $6,914 | $73 |
| Short return visit (20+ min) | 51 | $2,373 | $45 |
| New patient visit (30+ min) | 21 | $1,205 | $57 |
| New patient visit (15+ min) | 17 | $572 | $34 |
| Urinalysis, manual test | 43 | $151 | $3 |
2013: 4 services
| Return visit (30+ min) | 47 | $3,224 | $67 |
| Short return visit (20+ min) | 33 | $1,731 | $46 |
| New patient visit (30+ min) | 12 | $932 | $78 |
| Urinalysis, manual test | 14 | $42 | $3 |
Medicaid work
$693 in 2024
Medicaid paid $693 for 13 billed services this clinician did in 2024, up to 13 people in a month for one service.
Medicaid and CHIP claims where this clinician did the service, fee-for-service and managed care together. Any month with fewer than 11 patients is hidden, so small Medicaid practices undercount.
| Return visit (30+ min) | 13 | $693 |
| 2024 | 13 | 1 | 13 | $693 |
| 2022 | 14 | 1 | 14 | $765 |
| 2020 | 14 | 1 | 14 | $154 |
| 2018 | 45 | 2 | 17 | $2,197 |
See the largest Medicaid services in earlier years
2022
| Return visit (30+ min) | 14 | $765 |
2020
| Return visit (30+ min) | 14 | $154 |
2018
| Return visit (30+ min) | 33 | $1,994 |
| Infectious agent antigen detection by immunoassay with direct optical (ie, visual) observation; Streptococcus, group A | 12 | $203 |
Drugs they prescribed that Part D paid
$127,837
Pharmacies billed $127,837 in 2024.
This is pharmacy cost, not the office bill, and not what patients paid.
Opioids were 8% of their Part D prescriptions (267 of 3,476) in 2024. A higher opioid share than 9 in 10 peers; the typical family practice clinician is at 2%. Long-acting opioids: 5% of their opioid prescriptions.
3,134 generic and 311 brand-name prescriptions · $127,837 in drug cost · 198 antibiotic prescriptions to 182 people · 18 antipsychotic prescriptions to people over 65.
Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.
| Ozempic | 11 | $8,152 | $741 |
| Spiriva Respimat | 12 | $7,061 | $588 |
| Wixela Inhub | 32 | $5,414 | $169 |
| Hydrocodone-Acetaminophen | 155 | $4,026 | $26 |
| Pradaxa | 13 | $3,662 | $282 |
See all 79 drugs
| Ozempic | 11 | $8,152 | $741 |
| Spiriva Respimat | 12 | $7,061 | $588 |
| Wixela Inhub | 32 | $5,414 | $169 |
| Hydrocodone-Acetaminophen | 155 | $4,026 | $26 |
| Pradaxa | 13 | $3,662 | $282 |
| Alvesco | 26 | $2,822 | $109 |
| Albuterol Sulfate Hfa | 129 | $2,325 | $18 |
| Atorvastatin | 193 | $2,249 | $12 |
| Levothyroxine | 104 | $1,888 | $18 |
| Humulin N | 14 | $1,609 | $115 |
| Amlodipine Besylate | 123 | $1,431 | $12 |
| Losartan | 111 | $1,421 | $13 |
| Lisinopril | 115 | $1,388 | $12 |
| Oxycodone-Acetaminophen | 52 | $1,291 | $25 |
| Fluticasone Propionate | 60 | $1,162 | $19 |
| Terazosin | 16 | $1,057 | $66 |
| Gabapentin | 47 | $976 | $21 |
| Metformin | 58 | $812 | $14 |
| Atenolol | 66 | $771 | $12 |
| Tamsulosin | 58 | $758 | $13 |
| Hydrochlorothiazide | 68 | $726 | $11 |
| Metoprolol | 65 | $697 | $11 |
| Famotidine | 53 | $686 | $13 |
| Pantoprazole | 53 | $658 | $12 |
| Potassium Chloride | 22 | $656 | $30 |
| Ibuprofen | 46 | $571 | $12 |
| Simvastatin | 49 | $561 | $11 |
| Morphine Sulfate Er | 13 | $541 | $42 |
| Levetiracetam | 11 | $513 | $47 |
| Propranolol | 11 | $453 | $41 |
| Cephalexin | 69 | $437 | $6 |
| Clopidogrel | 23 | $415 | $18 |
| Lisinopril-Hydrochlorothiazide | 33 | $414 | $13 |
| Furosemide | 33 | $404 | $12 |
| Hydralazine | 24 | $385 | $16 |
| Omeprazole | 31 | $364 | $12 |
| Nystatin | 17 | $361 | $21 |
| Glipizide | 33 | $357 | $11 |
| Trazodone | 30 | $351 | $12 |
| Montelukast | 28 | $345 | $12 |
| Metoprolol | 29 | $338 | $12 |
| Allopurinol | 27 | $314 | $12 |
| Finasteride | 21 | $312 | $15 |
| Duloxetine | 15 | $296 | $20 |
| Nortriptyline | 11 | $278 | $25 |
| Metformin Hcl Er | 35 | $273 | $8 |
| Alendronate | 28 | $271 | $10 |
| Losartan-Hydrochlorothiazide | 24 | $262 | $11 |
| Veo Insulin | 11 | $247 | $22 |
| Pravastatin | 15 | $243 | $16 |
| Tizanidine | 20 | $241 | $12 |
| Triamcinolone Acetonide | 24 | $233 | $10 |
| Amoxicillin-Clavulanate Potass | 22 | $221 | $10 |
| Doxycycline Monohydrate | 11 | $208 | $19 |
| Diclofenac | 19 | $204 | $11 |
| Acyclovir | 17 | $202 | $12 |
| Ciprofloxacin | 20 | $190 | $9 |
| Temazepam | 13 | $189 | $15 |
| Naproxen | 16 | $189 | $12 |
| Azithromycin | 36 | $187 | $5 |
| Carvedilol | 15 | $183 | $12 |
| Meloxicam | 28 | $182 | $7 |
| Sertraline | 14 | $175 | $13 |
| Hydrocortisone | 15 | $174 | $12 |
| Quetiapine | 12 | $173 | $14 |
| Lorazepam | 17 | $167 | $10 |
| Spironolactone | 15 | $160 | $11 |
| Baclofen | 12 | $158 | $13 |
| Rosuvastatin | 13 | $157 | $12 |
| Lovastatin | 12 | $150 | $13 |
| Oxycodone | 13 | $142 | $11 |
| Sumatriptan | 14 | $142 | $10 |
| Methylprednisolone | 19 | $142 | $7 |
| Sulfamethoxazole-Trimethoprim | 17 | $122 | $7 |
| Prednisone | 14 | $107 | $8 |
| Tramadol | 15 | $104 | $7 |
| Fluconazole | 20 | $98 | $5 |
| Hydroxyzine | 11 | $97 | $9 |
| Methocarbamol | 13 | $89 | $7 |
Year by year
| 2024 | 3,476 | 1,983 | 8% (267) | 9% | $127,837 |
| 2023 | 373 | 262 | None | 9% | $5,863 |
| 2022 | 201 | 129 | None | None | $4,007 |
| 2021 | 72 | 59 | None | None | $1,302 |
| 2020 | 57 | 43 | None | None | $596 |
| 2019 | 38 | 27 | 0% (0) | None | $579 |
| 2018 | 158 | 126 | None | 13% | $5,205 |
| 2017 | 186 | 134 | None | 8% | $3,951 |
| 2016 | 50 | 44 | None | None | $620 |
| 2015 | 29 | 19 | None | None | $653 |
| 2014 | 174 | 112 | 11% (19) | None | $3,244 |
| 2013 | 239 | 79 | None | 29% | $16,408 |
Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.
See the drugs prescribed each year
2023: 12 drugs
| Cefuroxime | 14 | $523 | $37 |
| Amoxicillin-Clavulanate Potass | 32 | $420 | $13 |
| Albuterol Sulfate Hfa | 16 | $380 | $24 |
| Diclofenac | 22 | $345 | $16 |
| Nitrofurantoin Mono-Macro | 19 | $222 | $12 |
| Cephalexin | 31 | $191 | $6 |
| Methylprednisolone | 21 | $177 | $8 |
| Azithromycin | 29 | $128 | $4 |
| Ciprofloxacin | 14 | $117 | $8 |
| Paxlovid (Eua) | 11 | $112 | $10 |
| Sulfamethoxazole-Trimethoprim | 19 | $94 | $5 |
| Fluconazole | 15 | $90 | $6 |
2022: 9 drugs
| Amoxicillin-Clavulanate Potass | 12 | $166 | $14 |
| Quetiapine | 16 | $132 | $8 |
| Ciprofloxacin | 11 | $129 | $12 |
| Methylprednisolone | 11 | $119 | $11 |
| Azithromycin | 16 | $115 | $7 |
| Paxlovid (Eua) | 12 | $115 | $10 |
| Amoxicillin | 13 | $87 | $7 |
| Sulfamethoxazole-Trimethoprim | 14 | $82 | $6 |
| Cephalexin | 11 | $62 | $6 |
2021: 1 drug
| Diclofenac | 11 | $124 | $11 |
2018: 3 drugs
| Amoxicillin-Clavulanate Potass | 13 | $156 | $12 |
| Sulfamethoxazole-Trimethoprim | 11 | $71 | $6 |
| Cephalexin | 12 | $66 | $5 |
2017: 3 drugs
| Sulfamethoxazole-Trimethoprim | 13 | $87 | $7 |
| Azithromycin | 14 | $81 | $6 |
| Cephalexin | 16 | $74 | $5 |
2014: 5 drugs
| Amox Tr-Potassium Clavulanate | 14 | $197 | $14 |
| Azithromycin | 16 | $112 | $7 |
| Ciprofloxacin | 17 | $83 | $5 |
| Fluconazole | 12 | $46 | $4 |
| Hydrocodone-Acetaminophen | 12 | $46 | $4 |
2013: 1 drug
| Proair Hfa | 11 | $522 | $47 |
Money from drug and device companies
$191 in 2025
| 2025 | 8 | 9 | None | $191 |
| 2024 | 2 | 3 | None | $39 |
| 2023 | 1 | 2 | None | $33 |
Paid work is consulting, speaking, honoraria and royalties, as opposed to meals and travel.
A payment is not proof that care is biased.
| Otsuka America Pharmaceutical | Rexulti | $31 | 1 payment
|
| Inspire Medical Systems | Inspire | $31 | 1 payment
|
| Bayer Healthcare Pharmaceuticals | Kerendia | $30 | 2 payments
|
| Otsuka Pharmaceutical Development & Commercialization | Rexulti | $28 | 1 payment
|
| Abbvie | Qulipta | $20 | 1 payment
|
| Exact Sciences | Cologuard Collection Kit | $18 | 1 payment
|
See all 9 published payments
| Otsuka America Pharmaceutical | Meals · 2025-09-11 | Rexulti | $31 |
| Novo Nordisk | Meals · 2025-08-21 | Ozempic | $18 |
| Abbvie | Meals · 2025-05-22 | Qulipta | $20 |
| Otsuka Pharmaceutical Development & Commercialization | Meals · 2025-04-10 | Rexulti | $28 |
| Bayer Healthcare Pharmaceuticals | Meals · 2025-04-02 | Kerendia | $15 |
| Exact Sciences | Meals · 2025-03-21 | Cologuard Collection Kit | $18 |
| Inspire Medical Systems | Meals · 2025-03-13 | Inspire | $31 |
| Bayer Healthcare Pharmaceuticals | Meals · 2025-01-29 | Kerendia | $15 |
| Phathom Pharmaceuticals | Meals · 2025-01-16 | Voquezna | $14 |
See earlier years (2024, 2023)
2024: $39
| Boehringer Ingelheim Pharmaceuticals | Jardiance | $21 | 1 payment
|
| Novo Nordisk | Rybelsus | $19 | 1 payment
|
2023: $33
| AbbVie | Botox | $33 | 2 payments
|
Professional record
- NPI
- 1033138342
- Licence
- CA C133122, WA MD00037673California C133122: Current · expires 2028-06-30Washington MD.MD.00037673: Expired
- Trained
- Creighton University School of Medicine, 1997
- Group
- Sutter Valley Medical Foundation · Sutter Bay Medical Foundation
- Video visits
- Lists video visits
- Gender
- Female
More record details
- Sole proprietor
- No
- Medicaid ID
- WA 1033138342
- Taxonomy
- Family medicine (207Q00000X)
- Mailing address
- 10470 Old Placerville Rd, Suite 100, Sacramento, CA, 95827
- NPI first listed
- 2006-07-18
- NPI last updated
- 2014-12-05
This is when the NPI record was last certified, not a medical board exam.